A Multi-Scale Graph Neural Process with Cross-Drug Co-Attention for Drug-Drug Interactions Prediction

• URL: http://arxiv.org/abs/2509.15256v1
• Date: Thu, 18 Sep 2025 07:48:10 GMT
• Title: A Multi-Scale Graph Neural Process with Cross-Drug Co-Attention for Drug-Drug Interactions Prediction
• Authors: Zimo Yan, Jie Zhang, Zheng Xie, Yiping Song, Hao Li,
• Abstract summary: We propose MPNP-DDI, a novel Multi-scale Graph Neural Process framework.<n>The core of MPNP-DDI is a unique message-passing scheme that learns a hierarchy of graph representations at multiple scales.<n>MPNP-DDI significantly outperforms state-of-the-art baselines on benchmark datasets.
• Score: 16.181492817294743
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Accurate prediction of drug-drug interactions (DDI) is crucial for medication safety and effective drug development. However, existing methods often struggle to capture structural information across different scales, from local functional groups to global molecular topology, and typically lack mechanisms to quantify prediction confidence. To address these limitations, we propose MPNP-DDI, a novel Multi-scale Graph Neural Process framework. The core of MPNP-DDI is a unique message-passing scheme that, by being iteratively applied, learns a hierarchy of graph representations at multiple scales. Crucially, a cross-drug co-attention mechanism then dynamically fuses these multi-scale representations to generate context-aware embeddings for interacting drug pairs, while an integrated neural process module provides principled uncertainty estimation. Extensive experiments demonstrate that MPNP-DDI significantly outperforms state-of-the-art baselines on benchmark datasets. By providing accurate, generalizable, and uncertainty-aware predictions built upon multi-scale structural features, MPNP-DDI represents a powerful computational tool for pharmacovigilance, polypharmacy risk assessment, and precision medicine.

Related papers

• Rethinking Drug-Drug Interaction Modeling as Generalizable Relation Learning [14.217488560342135]
  Drug-drug interaction (DDI) prediction is central to drug discovery and clinical development.<n>We propose GenRel-DDI, a relation-centric learning framework that reformulates DDI prediction as a relation-centric learning problem.<n>Experiments show that GenRel-DDI consistently and significantly outperforms state-of-the-art methods.
  arXiv  Detail & Related papers  (2026-01-22T09:00:30Z)
• Predicting Drug-Drug Interactions Using Heterogeneous Graph Neural Networks: HGNN-DDI [8.48967497162918]
  Drug-drug interactions (DDIs) can lead to reduced therapeutic efficacy or severe adverse effects.<n>We propose HGNN-DDI, a graph neural network model designed to predict potential DDIs by integrating multiple drug-related data sources.<n> Experimental results on benchmark DDI datasets demonstrate that HGNN-DDI outperforms state-of-the-art baselines in prediction accuracy and robustness.
  arXiv  Detail & Related papers  (2025-08-26T07:50:47Z)
• KITE-DDI: A Knowledge graph Integrated Transformer Model for accurately predicting Drug-Drug Interaction Events from Drug SMILES and Biomedical Knowledge Graph [0.11049608786515838]
  Drug-Drug Interactions (DDI) can cause significant bodily injury and even death.<n>Most contemporary research for predicting DDI events relies on either information from Biomedical Knowledge graphs (KG) or drug SMILES.<n>In this study, we propose a KG-integrated Transformer architecture to generate an end-to-end fully automated Machine Learning pipeline.
  arXiv  Detail & Related papers  (2024-12-08T00:49:57Z)
• MIN: Multi-channel Interaction Network for Drug-Target Interaction with Protein Distillation [64.4838301776267]
  Multi-channel Interaction Network (MIN) is a novel framework designed to predict drug-target interaction (DTI)<n>MIN incorporates a representation learning module and a multi-channel interaction module.<n>MIN is not only a potent tool for DTI prediction but also offers fresh insights into the prediction of protein binding sites.
  arXiv  Detail & Related papers  (2024-11-23T05:38:36Z)
• RGDA-DDI: Residual graph attention network and dual-attention based framework for drug-drug interaction prediction [4.044376666671973]
  We propose RGDA-DDI, a residual graph attention network (residual-GAT) and dual-attention based framework for drug-drug interaction prediction. A series of evaluation metrics demonstrate that the RGDA-DDI significantly improved DDI prediction performance on two public benchmark datasets.
  arXiv  Detail & Related papers  (2024-08-27T17:13:56Z)
• Physical formula enhanced multi-task learning for pharmacokinetics prediction [54.13787789006417]
  A major challenge for AI-driven drug discovery is the scarcity of high-quality data. We develop a formula enhanced mul-ti-task learning (PEMAL) method that predicts four key parameters of pharmacokinetics simultaneously. Our experiments reveal that PEMAL significantly lowers the data demand, compared to typical Graph Neural Networks.
  arXiv  Detail & Related papers  (2024-04-16T07:42:55Z)
• Learning to Denoise Biomedical Knowledge Graph for Robust Molecular Interaction Prediction [50.7901190642594]
  We propose BioKDN (Biomedical Knowledge Graph Denoising Network) for robust molecular interaction prediction. BioKDN refines the reliable structure of local subgraphs by denoising noisy links in a learnable manner. It maintains consistent and robust semantics by smoothing relations around the target interaction.
  arXiv  Detail & Related papers  (2023-12-09T07:08:00Z)
• Emerging Drug Interaction Prediction Enabled by Flow-based Graph Neural Network with Biomedical Network [69.16939798838159]
  We propose EmerGNN, a graph neural network (GNN) that can effectively predict interactions for emerging drugs. EmerGNN learns pairwise representations of drugs by extracting the paths between drug pairs, propagating information from one drug to the other, and incorporating the relevant biomedical concepts on the paths. Overall, EmerGNN has higher accuracy than existing approaches in predicting interactions for emerging drugs and can identify the most relevant information on the biomedical network.
  arXiv  Detail & Related papers  (2023-11-15T06:34:00Z)
• Multi-View Substructure Learning for Drug-Drug Interaction Prediction [69.34322811160912]
  We propose a novel multi- view drug substructure network for DDI prediction (MSN-DDI) MSN-DDI learns chemical substructures from both the representations of the single drug (intra-view) and the drug pair (inter-view) simultaneously and utilizes the substructures to update the drug representation iteratively. Comprehensive evaluations demonstrate that MSN-DDI has almost solved DDI prediction for existing drugs by achieving a relatively improved accuracy of 19.32% and an over 99% accuracy under the transductive setting.
  arXiv  Detail & Related papers  (2022-03-28T05:44:29Z)
• Multiple Similarity Drug-Target Interaction Prediction with Random Walks and Matrix Factorization [16.41618129467975]
  We take a multi-layered network perspective, where different layers correspond to different similarity metrics between drugs and targets. To fully take advantage of topology information captured in multiple views, we develop an optimization framework, called MDMF, for DTI prediction. The framework learns vector representations of drugs and targets that not only retain higher-order proximity across all hyper-layers, but also approximates the interactions with their inner product.
  arXiv  Detail & Related papers  (2022-01-24T08:02:05Z)
• AttentionDDI: Siamese Attention-based Deep Learning method for drug-drug interaction predictions [0.9176056742068811]
  Drug-drug interactions (DDIs) refer to processes triggered by the administration of two or more drugs leading to side effects beyond those observed when drugs are administered by themselves. Due to the massive number of possible drug pairs, it is nearly impossible to experimentally test all combinations and discover previously unobserved side effects. We propose a Siamese self-attention multi-modal neural network for DDI prediction that integrates multiple drug similarity measures.
  arXiv  Detail & Related papers  (2020-12-24T13:33:07Z)
• SumGNN: Multi-typed Drug Interaction Prediction via Efficient Knowledge Graph Summarization [64.56399911605286]
  We propose SumGNN: knowledge summarization graph neural network, which is enabled by a subgraph extraction module. SumGNN outperforms the best baseline by up to 5.54%, and the performance gain is particularly significant in low data relation types.
  arXiv  Detail & Related papers  (2020-10-04T00:14:57Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.